We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Allos Therapeutics, Inc. (MM) | NASDAQ:ALTH | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 1.83 | 0 | 01:00:00 |
From Jul 2019 to Jul 2024
The full report is available at: www.microstockprofit.com/lp/ALTH
Allos Therapeutics Inc. (ALTH) is a biopharmaceutical company engaged in the development and commercialization of anti-cancer therapeutics. The Company is focused on the development and commercialization of FOLOTYN (pralatrexate injection), a targeted antifolate inhibitor designed to accumulate preferentially in cancer cells.
This newsletter has been helping traders make great investment decisions on ALTH; click here for a 25% discount offer.
In the report, the analyst notes:
"Shares of ALTH spiked more than 8% Thursday after the cancer drug maker presented data from COMPLETE, an international registry designed to address the urgent need for an increased understanding of the treatment patterns and outcomes for patients with peripheral T-cell lymphoma (PTCL)."
"It is unique in that it is the first registry designed to characterize treatment patterns across practice settings in the United States and Europe for patients with PTCL, said Charles Morris MB ChB, MRCP, chief medical officer at ALTH."
To read the entire report visit: www.microstockprofit.com/lp/ALTH
See what investors are saying about ALTH at http://www.stockhideout.com
Get breaking news on ALTH at http://thestockmarketwatch.com/
MicroStockProfit.com is a small-cap research and investment commentary provider. MicroStockProfit.com strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on MicroStockProfit please visit: http://www.microstockprofit.com
MicroStockProfit.com Disclosure
MicroStockProfit.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. MicroStockProfit.com is a Web site wholly owned by BlueWave Advisors, LLC. Neither MicroStockProfit.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. Please read our report and visit our Web site, MicroStockProfit.com, for complete risks and disclosures.
Hot Features
Premium
CONTACT: Jay Geller
info@microstockprofit.com
1-888-307-2850
1 Year Allos Therapeutics, Inc. (MM) Chart |
1 Month Allos Therapeutics, Inc. (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
